On the Dangers of Navel Gazing: Lessons Learned from UK Retailer’s Lack of External Market View

Posted by Ken Sawka on May 31, 2018 1:40:11 PM

Being Too "Inward Looking"

Steve Rowe, CEO of UK-based retailer Marks & Spencer (M&S), last week acknowledged the secret that most corporate executives try to keep hidden: that his company has become too “inward looking.” In an interview with the BBC, Rowe admitted that part of the retail chain’s troubles are due to its failure to keep pace with external trends, namely consumer behavior and e-commerce. 

Read More

Topics: Market Analysis, Competitive Strategy, strategic planning, Retail

How CVS Health’s Performance-Based Pharmacy is Positioned to Improve Cost and Quality across the Healthcare Continuum

Posted by Jacob Golbitz on Apr 6, 2018 12:23:26 PM

CVS Health issued a press release in October 2017 announcing the launch of the nation’s first “performance-based pharmacy network” in March 2018. The network will comprise approximately 30,000 retail pharmacies that currently work with Caremark, CVS Health’s Pharmacy Benefits Manager (PBM). Most of these stores will be CVS or Walgreens locations, but the network will also include up to 10,000 independently owned pharmacies.

Read More

Topics: New Market Entry, Healthcare, Competitive Strategy, Diversification, Insurers

How Distributors Can Navigate the Fragmentation of Vaccine Administration

Posted by Laura Ruth on Apr 3, 2018 9:15:08 AM

Read More

Topics: Market Analysis, New Market Entry, Healthcare, Life Sciences, Competitive Strategy, new entrants

Walmart’s Potential Acquisition of Humana: Competitive Strategy Implications for the U.S. Healthcare Industry

Posted by Ken Sawka on Mar 30, 2018 1:28:34 PM

 

I loathe the pervasive, trite metaphor that compares competitive strategy to the game of chess.  However, recent reports that Walmart is in discussions to acquire health insurer Humana can only be explained as a game of three-dimensional chess.  Should this deal go through – and, to be sure, it is a long way from happening – it satisfies three competitive strategy objectives for Walmart: responding to CVS Health, blocking Amazon and improving access to new customer segments.

Read More

Topics: Competitive Intelligence, Healthcare, Merger and Acquisition, Competitive Strategy

Key Takeaways from the Institute of Directors Open House, 12-14 March 2018, London

Posted by Ken Sawka on Mar 27, 2018 6:24:18 PM

The Institute of Directors (IoD), founded in 1903 and awarded a Royal Charter in 1906 is an organization that supports and advocates for businesses and their leaders in the United Kingdom. The IoD serves its members by promoting free enterprise, actively lobbying to the government and helping set standards for corporate governance. Fuld + Company became a member of the IoD this year and were pleased to attend this year’s Open House, held from 12-14 March 2018 at the IoD’s stately headquarters just steps from Buckingham Palace.

Read More

Topics: Competitive Strategy, Conferences

Supply Chain Shifts in the Ever-Tumultuous Health Industry

Posted by Robert Flynn on Jan 19, 2018 3:33:19 PM

Capitalism has its flaws. Economists as diverse as Adam Smith to Karl Marx would agree to this premise. Yet one strength that capitalism brings to bear in the marketplace is efficiency, particularly the ability to identify and capture substitute products and services when supply and demand constrains efficient market activity. Nowhere is this dynamic more apparent than in the seemingly ever-tumultuous health industry.

Read More

Topics: Competitive Intelligence, Pharma, Scenario Analysis, Competitive Strategy, Robert Flynn, Pharmaceuticals

The Rideshare Opportunity in Kenya and Across Sub-Saharan Africa

Posted by Ben Price on Jan 16, 2018 4:04:51 PM

Nairobi, Kenya, the hub of East Africa, is a bustling city marked by contradictions – for example, it houses a combination of highly developed corporate high-rise offices and traditional African trade markets consisting of temporary kiosks and relatively permanent dukas. A more tangible contradiction is in transportation. A recent boom in automobile sales has plagued the city with horrendous traffic due to poor road infrastructure. Yet for those many who cannot afford to own a vehicle, transportation comes in the form of taxis, mutatus (buses), and Uber.

Read More

Topics: Competitive Intelligence, Product Roadmap, Brand Insights, Scenario Analysis, Competitive Strategy, Early Warning

What are the Competitive Strategy Implications of Uber's European Regulatory Woes?

Posted by Ken Sawka on Jan 10, 2018 10:44:04 PM

Let me be clear right from the start – I loathe Uber. While I’m a big fan of ride-hailing services, I simply can’t give my business to a company that harasses its employees, whose CEO berates its drivers, uses questionable means to skirt regulation, and allegedly steals trade secrets from its competitors. I’m a Lyft guy through and through.

Read More

Topics: Brand Insights, Industry Convergence, Merger and Acquisition, Competitive Strategy, Early Warning

Managing Regulatory and Political Risk

Posted by Robert Flynn on Nov 21, 2017 3:38:26 PM

In our paper The Global Economy’s New Frontiers, my colleague Nathaniel Emmons and I argue that when investing in emerging economies, companies can realize high returns but only if the risks are successfully managed. Transnational mining companies operating in Zimbabwe, for instance, are in crisis management mode following this month’s coup, impeachment of President Mugabe, and transfer of power to yet another strong-man. Not an unanticipated series of events given the political instability experienced in recent years, and something that needs intense effort to navigate.

Read More

Topics: Consumer Goods, Healthcare, Merger and Acquisition, Competitive Strategy, Early Warning

CVS – Aetna: The Power of Strategic Competitive Analysis

Posted by Robert Flynn on Oct 27, 2017 2:46:39 PM

The Wall Street Journal and other sources revealed yesterday that pharmacy operator CVS Health Corporation has made an offer to acquire No. 3 health insurer Aetna Inc.  Wouldn’t it have been rewarding to have known the probability of such an acquisition?  Wouldn’t executives of Walgreens and Express Scripts or United Health Group and Anthem have benefited from an evaluation that showed the rationale for such an acquisition? Fuld + Company analysis produced in June 2017 did precisely that. Anticipating just such a move four months ago demonstrates of the power of competitive strategy.

Read More

Topics: Competitive Intelligence, War Games, Early Warning Monitoring, Healthcare, Competitive Strategy

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Recent Posts

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.